Canada based Golden Leaf Holdings Ltd (OTCMKTS:GLDFF), a prominent Cannabis oil/ solution provider, has announced the selection of Mr. Craig Eastwood as a Chief Financial Officer. He will take the charge as CFO at Golden Leaf from January 15, 2018. He is given the charge of managing balance sheet risk, liquidity, as well as capital market transactions. His main role is to capitalize the growth opportunities for Golden Leaf and steer it in a growth path. He will be functionally reporting to the Chief Executive Officer, Mr. William Simpson.
Mr. Eastwood has around 30 years of leadership experience in the financial cadre and his recent stunt includes a Chief Financial Officer of Powin Energy Corp (OTCMKTS:PWON). He also worked as a corporate controller at a specialty aviation firm – Erickson.
According to Mr. William Simpson, the appointment of Craig came at the right time to steer the company to a growth path with his financial background. The company is currently focusing on expanding the footprint in Oregon and the new markets in Canada and Nevada.
Medical Marijuana Group (MMG), a subsidiary of Golden Leaf Holdings Ltd, Announces the Receipt of the First Genetics Shipment
Golden Leaf Holdings Ltd’s subsidiary Medical Marijuana Group (MMG) has announced the receipt of the first shipment of the Genetics at Ontario Facility. It transitions the facility at St. Thomas into a fully functional manufacturing unit.
According to the leadership at Golden Leaf, the plants will be ready for plantation in the forthcoming three months. The company is aiming to maintain a product flow with expected additional shipments in the coming months.
MMG has submitted applications for wholesale licenses as well as for oil extraction to Health Canada. The company is anticipating the sales license in May 2018.
MMG has already received the cultivation license Q4, 2017. The company has the latest manufacturing technology and quality procedures in place to ensure production of good quality products.
The company is planning for big expansion in 2018 to target the adult market in Canada to cash in on the growing medical sector opportunities. The genetics portfolio of strains with the highest concentration of CBD, which is in great demand in Canada.